Multiple Sclerosis
Pharma company reports discovery of new gene involved in multiple sclerosis
Published in AIDS Weekly, January 30th, 2006
Although the gene and some of its functions are already known, this is the first evidence of involvement with the disease state of MS. The research also provides evidence that RPI-78M modulates the expression of this gene in laboratory assays. RPI-78M is the lead drug candidate of Nutra Pharma's holding, ReceptoPharm, Inc. and is being studied in preclinical assays for its efficacy in treating MS.
Eno Research and Development, Inc. (ERDI) was contracted by Nutra Pharma to analyze samples...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2006-01-30)
More Articles from AIDS Weekly
- Drug Development
Indirubin-3'-monoxime inhibits P-TEFb function and HIV-1 replication - HIV/AIDS Drug Delivery
Zidovudine plasma levels increase when dosed as a prodrug in liposomal form - HIV/AIDS Drug Resistance
Drug-resistance mutations identified in HAART-naive HIV-infected patients - HIV/AIDS Therapy
Dextrin sulphate against HIV is well tolerated without systemic absorption - HIV/AIDS Vertical Transmission
Lower vertical HIV-1 transmission in boys independent of type of delivery or prophylaxis - Allergy & Immunology
Intracisternal A-type retroviral particle type I isolated from SLE patients - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
